Treatment algorithms for patients with metastatic non-small cell, non-squamous lung cancer

被引：16

作者：

Melosky, Barbara ^{[1
]}

机构：

[1] British Columbia Canc Agcy, Vancouver Ctr, Med Oncol, 600 West 10th Ave, Vancouver, BC V5Z 4E6, Canada

来源：

FRONTIERS IN ONCOLOGY | 2014年 / 4卷

关键词：

metatstatic non-squamous NSCLC; systemic therapy; chemotherapy; targeted therapy;

D O I：

10.3389/fonc.2014.00256

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A number of developments have altered the treatment paradigm for metastatic non-small cell, non-squamous lung cancer. These include increasing knowledge of molecular signal pathways, as well as the outcomes of several large-scale trials. As a result, treatments are becoming more efficacious and more personalized, and are changing the management and prognosis of non-small cell lung cancer patients. This is resulting in increased survival in select patient groups. In this paper, a simplified algorithm for treating patients with metastatic non-small cell, non-squamous lung cancer is presented.

引用

页数：5

共 29 条

[1] ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers [J].

Bergethon, Kristin ;

Shaw, Alice T. ;

Ou, Sai-Hong Ignatius ;

Katayama, Ryohei ;

Lovly, Christine M. ;

McDonald, Nerina T. ;

Massion, Pierre P. ;

Siwak-Tapp, Christina ;

Gonzalez, Adriana ;

Fang, Rong ;

Mark, Eugene J. ;

Batten, Julie M. ;

Chen, Haiquan ;

Wilner, Keith D. ;

Kwak, Eunice L. ;

Clark, Jeffrey W. ;

Carbone, David P. ;

Ji, Hongbin ;

Engelman, Jeffrey A. ;

Mino-Kenudson, Mari ;

Pao, William ;

Iafrate, A. John .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) :863-870

[2] Maintenance therapies for non-small cell lung cancer [J].

Blais, Normand ;

Kassouf, Elie .

FRONTIERS IN ONCOLOGY, 2014, 4

[3] Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study [J].

Cappuzzo, Federico ;

Ciuleanu, Tudor ;

Stelmakh, Lilia ;

Cicenas, Saulius ;

Szczesna, Aleksandra ;

Juhasz, Erzsebet ;

Esteban, Emilio ;

Molinier, Olivier ;

Brugger, Wolfram ;

Melezinek, Ivan ;

Klingelschmitt, Gaelle ;

Klughammer, Barbara ;

Giaccone, Giuseppe .

LANCET ONCOLOGY, 2010, 11 (06) :521-529

[4] Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study [J].

Ciuleanu, Tudor ;

Brodowicz, Thomas ;

Zielinski, Christoph ;

Kim, Joo Hang ;

Krzakowski, Maciej ;

Laack, Eckart ;

Wu, Yi-Long ;

Bover, Isabel ;

Begbie, Stephen ;

Tzekova, Valentina ;

Cucevic, Branka ;

Pereira, Jose Rodrigues ;

Yang, Sung Hyun ;

Madhavan, Jayaprakash ;

Sugarman, Katherine P. ;

Peterson, Patrick ;

John, William J. ;

Krejcy, Kurt ;

Belani, Chandra P. .

LANCET, 2009, 374 (9699) :1432-1440

[5] The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR-Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial [J].

Costa, Carlota ;

Molina, Miguel Angel ;

Drozdowskyj, Ana ;

Gimenez-Capitan, Ana ;

Bertran-Alamillo, Jordi ;

Karachaliou, Niki ;

Gervais, Radj ;

Massuti, Bartomeu ;

Wei, Jia ;

Moran, Teresa ;

Majem, Margarita ;

Felip, Enriqueta ;

Carcereny, Enric ;

Garcia-Campelo, Rosario ;

Viteri, Santiago ;

Taron, Miquel ;

Ono, Mayumi ;

Giannikopoulos, Petros ;

Bivona, Trever ;

Rosell, Rafael .

CLINICAL CANCER RESEARCH, 2014, 20 (07) :2001-2010

[6] Ancillary Testing in Lung Cancer Diagnosis [J].

Dubinski, William ;

Leighl, Natasha B. ;

Tsao, Ming-Sound ;

Hwang, David M. .

PULMONARY MEDICINE, 2012, 2012

[7] A Systematic Review and Canadian Consensus Recommendations on the Use of Biomarkers in the Treatment of Non-small Cell Lung Cancer [J].

Ellis, Peter M. ;

Blais, Normand ;

Soulieres, Dennis ;

Ionescu, Diana N. ;

Kashyap, Meenakshi ;

Liu, Geoff ;

Melosky, Barb ;

Reiman, Tony ;

Romeo, Phillippe ;

Shepherd, Frances A. ;

Tsao, Ming-Sound ;

Leighl, Natasha B. .

JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (08) :1379-1391

[8]

GAZDAR AF, 1988, SEMIN ONCOL, V15, P215

[9] Maintenance treatment after induction therapy in non-small cell lung cancer: latest evidence and clinical implications [J].

Gentzler, Ryan D. ;

Patel, Jyoti D. .

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2014, 6 (01) :4-15

[10] Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy [J].

Hanna, N ;

Shepherd, FA ;

Fossella, FV ;

Pereira, JR ;

De Marinis, F ;

von Pawel, J ;

Gatzemeier, U ;

Tsao, TCY ;

Pless, M ;

Muller, T ;

Lim, HL ;

Desch, C ;

Szondy, K ;

Gervais, R ;

Shaharyar ;

Manegold, C ;

Paul, S ;

Paoletti, P ;

Einhorn, L ;

Bunn, PA .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1589-1597

← 1 2 3 →